Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has shared an announcement.
Proteomics International Laboratories Ltd has announced a significant expansion of its Share Purchase Plan (SPP) due to overwhelming demand, receiving applications exceeding $7.5 million, far surpassing the initial $1 million target. The company will issue 10,177,982 new options to accommodate all valid applications, thereby increasing its capital structure significantly and enhancing its market position by allowing more stakeholders to participate in its growth.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd is a company operating in the biotechnology industry, specializing in the development of diagnostic tests and analytical services. The company focuses on proteomics, the large-scale study of proteins, which plays a crucial role in understanding diseases and developing new therapies.
Average Trading Volume: 147,943
Technical Sentiment Signal: Sell
Current Market Cap: A$56.73M
See more insights into PIQ stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue